Medical Claims Consulting Services for Infectious Disease Practices

An A/R consultant reviews unpaid and aging claims, organizes balances by payer, service type, and claim characteristics, and identifies why payment has stalled. In infectious disease practices, that may include infusion drug claims, hospital consult claims, and complex outpatient visits. The consultant can support follow-up, document payer contacts, identify recurring workflow problems, and connect unresolved balances to broader revenue-cycle improvements.

Medical claims consulting can include claims management, coding review, claim scrubbing, rejection clearing, denial categorization, payer-specific appeals, eligibility and authorization support, payment reconciliation, underpayment review, and A/R follow-up. For infectious disease practices, the work may also address infusion, OPAT, drug, administration, evaluation and management, hospital consult, and specialty-drug claims, depending on the practice’s services and workflow.

Infectious disease practices may manage cognitive services alongside infusion, OPAT, drug acquisition, administration billing, hospital coverage arrangements, and multiple payer benefit structures. Claims can be affected by documentation, coding, authorization, medical versus pharmacy benefit rules, units, NDC information, contracts, and charge capture. Reviewing the full workflow helps identify whether a payment issue began clinically, operationally, contractually, or during claim processing.

Yes. Revenue leakage can occur through under-leveled visits, missed drug or administration charges, incomplete documentation, charge-capture gaps, or workflow breakdowns before submission. Reporting by payer, service line, and provider can help show patterns and connect missing revenue to its source. The resulting findings can guide practical changes in documentation, coding, workflow, or contract review.

A practice can reconcile payments against expected reimbursement for drug, administration, and evaluation and management claims. The review should examine whether the correct contract terms, fee schedules, units, and NDC information were applied. Short-pays and mismatches can then be documented, disputed, and tracked through resolution. The exact review criteria should reflect the practice’s payer agreements and claim types.

Authorization support may include verifying eligibility and benefits, determining whether therapy falls under the medical or pharmacy benefit, and managing requests for infusions, OPAT courses, and specialty drugs. Tracking each request helps the practice maintain visibility into outstanding requirements and reduce the risk of providing therapy without a clear reimbursement pathway. Requirements vary by payer, therapy, and patient coverage.

Common root causes can include drug and administration coding issues, missing authorization, confusion between medical and pharmacy benefits, and under-documented consultations. A structured denial process categorizes these causes, supports payer-specific appeals with relevant clinical documentation, and shares findings with clinical, coding, and front-office teams. Addressing the underlying pattern is important because appealing individual claims alone may not prevent recurrence.

The service is relevant to infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. It can support teams launching an infusion suite or OPAT program, adding providers, assessing payer and hospital coverage arrangements, managing claims backlogs, or investigating why collections do not reflect the work being performed. The appropriate focus depends on the practice’s services and operational questions.